On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.

Zhitongcaijing · 1d ago
On November 2, Changshan Pharmaceutical stated on an interactive platform that the company currently has no patents for albumin-coupled dual-target GLP-1 and albumin-coupled three-target GLP-1.